Glyndon, Maryland – April 4, 2016 – Due to the fundraising efforts of Believe Big, Johns Hopkins is preparing to begin a clinical trial on Mistletoe Extract to help “Kiss Cancer Goodbye.” Not only has Mistletoe been found to diminish tumor-related pain, increase the immune response, prevent reoccurrence during the watchful waiting period, but it also offsets the harsh side affects of chemotherapy: nausea, vomiting, and lack of appetite.
Most clinical trials are typically funded by pharmaceutical companies, but because Mistletoe is a natural substance, this is not an option. This is truly historic because this clinical trial is entirely patient driven and is being entirely funded by private donations. Even though Mistletoe is used all over the world and proven effective in treating cancer, until a clinical trial is done here in the United States, oncologists cannot offer this treatment as standard of care. Currently only 50 physicians are trained to treat with Mistletoe in the US. “We have been able to raise over $395,000 to start the clinical trail,” said Ivelisse Page, Executive Director & Co-founder of Believe Big. While European oncologists have used extracts of Mistletoe for the past 90 years, it is not available through oncologists in the U.S. Currently, 1 out of every 3 oncologists in Germany prescribes Mistletoe.
Believe Big is a non-profit organization formed in 2011 to help bridge the gap between conventional and complementary medicine for fighting cancer. Now Believe Big and Johns Hopkins are collaborating on a Mistletoe clinical trial that brings the conventional and complementary medical communities together. Johns Hopkins researchers say Mistletoe treatment could change the way doctors go after cancer. Believe Big founder, Ivelisse Page was healed of stage 4 colon cancer using Mistletoe Extract, surgery, and a high alkaline diet. She is now 7 years cancer free and the health advocate that began this effort. Dr. Luis Diaz, professor of oncology and senior researcher at Johns Hopkins, and Dr. Peter Hinderberger, expert in complementary medicine, both treated Ivelisse and are helping to lead the clinical trial at Johns Hopkins along with Dr. Channing Paller. Dr. Hinderberger has used Mistletoe in his practice successfully for over three decades. The clinical trial team is hoping that with this study, Mistletoe will be included in the standard of care treatment protocol for cancer.
For more information about Believe Big and to find a physician who is currently treating with Mistletoe, visit http://www.believebig.org
Anyone wishing to be a part of this historic event can make a tax-deductible donation for this trial by visiting: www.believebig.org/Donate.html
Disclaimer: The content in this press release is for information purposes only and should not be considered a substitute for medical advice. As always, you should consult with a qualified healthcare professional before starting or stopping any medication, nutritional supplement or protocol.
Distributed by PRD Press Release Distribution
Company Name: Believe Big
Contact Person: Ivelisse Page, Executive Director
Country: United States